Ayurveda associates vision with Alochaka Pitta, located in the eyes and linked with rupa-grahana, apprehension of visible form. This is a classical model, not a modern biochemical explanation. Eye diseases are not all Pitta disorders: the texts also describe Vata, Kapha, Rakta, combined-dosha, traumatic, and external causes. Chakshushya and netrya mean traditionally eye-supportive; they do not prove efficacy for myopia, cataract, glaucoma, macular disease, or retinal degeneration.

The Classical Framework of Netra

The opening chapter of the Sushruta Samhita‘s Uttara Tantra describes five mandalas, six sandhis, and six patalas, including two of the eyelids and four of the eye proper. It enumerates 76 eye diseases: 10 attributed to Vata, 10 to Pitta, 13 to Kapha, 16 to vitiated blood, 25 to combined doshas, and two to external causes. Diseases are also grouped by ocular site. This sophisticated Shalakya Tantra framework should not be mapped one-to-one onto modern anatomy or diagnoses; a translated term is not automatically cataract, glaucoma, or retinal disease.

Verified Chakshushya and Netrya Drugs

The Ayurvedic Pharmacopoeia of India verifies identity, quality standards, and recorded traditional properties. It does not establish that an oral herb reverses structural eye disease. Plant part, product quality, interactions, pregnancy status, tolerance, and diagnosis matter.

Amalaki (Emblica officinalis, syn. Phyllanthus emblica)

The official monograph gives Amalaki madhura, amla, katu, tikta, and kashaya rasa; laghu and ruksha guna; shita virya; and madhura vipaka. Its actions include tridoshajit, rasayana, and chakshushya. It identifies ascorbic acid and tannins or gallotannins, but not the claims that Amalaki has the world’s highest vitamin C content, that its vitamin C is fully heat-stable, or that its polyphenols have a special proven affinity for the retina.

Laboratory and selenite-rat cataract findings do not show that Amalaki prevents or treats human cataract, glaucoma, myopia, or macular disease. It cannot replace refraction, retinal imaging, pressure measurement, prescribed treatment, or surgery.

Triphala and Haritaki (Terminalia chebula)

Triphala combines Haritaki, Bibhitaki, and Amalaki. The Pharmacopoeia records Amalaki and Haritaki as chakshushya. Haritaki has five tastes other than salty, laghu and ruksha guna, ushna virya, and madhura vipaka. The unsupported attribution of Haritaki as the primary treatment for deep retinal disease in a specific Ashtanga Hridaya chapter has been removed.

A 2010 study tested Triphala in an in-vitro lens model and selenite-treated rats. It was not a human glaucoma trial and did not show reduced intraocular pressure in patients. No verified 2018 paper matching the claimed Triphala retinal neuroprotection through Nrf2 was located.

Shatavari (Asparagus racemosus)

The Shatavari root monograph records madhura and tikta rasa, guru and snigdha guna, shita virya, and madhura vipaka. Its actions include netrya, and its use list includes naktandhya, commonly glossed as night blindness. This does not verify that Shatavari is the primary internal treatment for dry eye or that its saponins clinically restore the conjunctival mucin layer.

Mild dryness is commonly managed with sterile artificial tears and lifestyle measures; persistent pain, redness, light sensitivity, or blurred vision needs examination. Shatavari should never be placed in the eye.

Punarnava (Boerhaavia diffusa)

The Pharmacopoeia records madhura, tikta, and kashaya rasa, ruksha guna, ushna virya, and madhura vipaka. Its actions include shothahara, mutrala, anulomana, and vata-shleshmahara; listed uses are shotha and pandu. It is not identified as the primary medicine for conjunctivitis, haemorrhage, tearing, floaters, or eye puffiness.

The claimed 2011 Phytomedicine NSAID-comparison study could not be verified. A red, painful, discharging, injured, or suddenly vision-impaired eye should not be self-treated with Punarnava or a homemade preparation.

Classical Formulations: What Is Actually Verified

An official monograph verifies composition, manufacturing standards, and traditional uses, not modern clinical effectiveness. Medicated ghees and mineral-containing medicines require quality-controlled manufacture and practitioner selection.

Anu Taila is a nasal oil, not a proven eye lubricant. Pushyanuga Churna is not a verified treatment for vitreous opacity or floaters. New floaters, flashes, or a curtain-like shadow can indicate retinal detachment and require urgent examination.

Netra Tarpana: Classical Procedure, Modern Limits

Netra Tarpana is a local ocular kriyakalpa procedure. A boundary is formed around the orbit and prescribed medicated ghee is retained while the patient opens and closes the eyes under supervision. It is not a home eye bath, and evidence does not show that surface medicines reach the retina or optic nerve in therapeutic amounts.

The dry-eye study compared two ghee preparations rather than Tarpana with sterile artificial tears, placebo, or no treatment. Its findings are preliminary. Homemade Triphala, Amalaki, honey, ghee, rose-water, or decoction eye drops are not recommended: cloth straining does not make them sterile or particle-free. Contact-lens users should use only approved sterile solutions and prescribed products.

A Safe Daily Routine for Screen-Related Eye Strain

Screen discomfort commonly reflects reduced blinking, prolonged near focus, glare, poor ergonomics, and dry air; it does not explain progressive myopia or retinal findings without examination.

• Take distance breaks: about every 20 minutes, look roughly 20 feet away for at least 20 seconds and blink fully.
• Improve ergonomics: keep the screen comfortably distant and slightly below eye level, enlarge text, and reduce glare.
• Protect the tear film: avoid direct fan or air-conditioner flow, consider a humidifier, and ask about preservative-free artificial tears.
• Respect sleep: bright evening screens can delay sleep, but routine screen blue light has not been shown to damage the retina.
• Avoid medicinal kajal or surma: many traditional products contain lead. Do not apply cosmetics inside an irritated eye.

Trataka may be contemplative if comfortable, but it is not an established treatment for refractive error or retinal disease and has not been shown to strengthen eye muscles. Stop if it causes pain, headache, tearing, or prolonged after-images.

For related reading, see Ayurveda for esports and gamers: protecting eyes.

When Ayurveda Must Not Delay Eye Care

Sudden floaters, flashes, a curtain or shadow in vision, sudden loss or distortion of vision, severe pain, chemical exposure, trauma, marked light sensitivity, or a red eye with reduced vision requires urgent assessment. Progressive myopia and suspected macular, retinal, optic-nerve, or glaucoma-related change require follow-up with an optometrist or ophthalmologist even when Ayurvedic support is used.

Consult a qualified Ayurvedic practitioner and an ophthalmologist before beginning any eye-treatment protocol. Never place food, oil, ghee, honey, plant juice, powder, decoction, or another non-sterile preparation directly in the eye. Ayurvedic care should complement, not replace, diagnosis, monitoring, prescribed eye drops, laser treatment, injections, or surgery when indicated.

References

1. Charaka Samhita — Pitta dosha
2. Wisdomlib — classical text
3. Ayurvedic Pharmacopoeia of India
4. Miracledrinksclinic (miracledrinksclinic.com)
5. Miracledrinksclinic (miracledrinksclinic.com)
6. Miracledrinksclinic (miracledrinksclinic.com)
7. Natural Ingredient Resource Center
8. Evaluation of anticataract potential of Triphala in selenite-induced cataract: In vitro and in vivo studies (2010), PubMed
9. Efficacy of Triphala Ghrita and Goghrita Manda Tarpana in the management of Shushkakshipaka w.s.r. to dry eye syndrome: An open labelled randomized comparative clinical trial (2020), PubMed
10. Nei (nei.nih.gov)
11. Nei (nei.nih.gov)
12. Aao (aao.org)
13. FDA